NASDAQ:CCXI

ChemoCentryx, Inc Earning Date

USA |NASDAQ |USD

CCXI Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.48 $-0.56 $-0.35
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $10.98M $1.81M $5.03M

Chemocentryx, Inc's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

CCXI Earnings Date & History Chart

CCXI Earnings & Revenue Forecast

CCXI Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $-0.33 $-0.72 $0.03
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $-1.80 $-2.31 $-1.28
Dec 2022 8 $-1.98 $-2.71 $-1.34

CCXI Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 4 / 3 $-0.48 $-0.49 $-0.49
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 4 / 3 $-1.96 $-1.99 $-1.98
Dec 2022 4 / 3 $-2.15 $-2.01 $-1.85

CCXI Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 8 $25.83M $5.47M $48.19M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $48.94M $20.09M $82.36M
Dec 2022 8 $90.31M $52.56M $118.30M

CCXI Earnings Date & Revenue History

CCXI Earnings History

|
Show More
Show More

CCXI Revenue History

|
Show More
Show More

Chemocentryx, Inc Next Earnings Date & Report

CCXI Next Earnings Date & Report Preview: Sep 2021 (FQ)

CCXI's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 8 analysts, the average EPS estimation for Chemocentryx, Inc's next quarterly earnings is $-0.48, with a low EPS estimation of $-0.68, and a high estimation of $-0.31.

Over the last 1 month, EPS estimates have seen 2 upward revisions and 2 downward. The EPS 1 month trend is $-0.49, the last 2 month trend is $-0.50, and the 3 month trend is $-0.52.

Based on 8 analysts, the average revenue estimation is $10.98M, with a low revenue estimation of $2.50M, and a high estimation of $22.00M.

Chemocentryx, Inc Previous Earnings Dates & Reports

CCXI Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Chemocentryx, Inc's previous earnings date was Aug 9, 2021 for its fiscal quarter ended Jun 30, 2021.

CCXI's earnings per share (EPS) was $-0.56, missing the consensus analysts forecast of $-0.54 by -2.96%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 30.23%, and lower than the same period a year before (Jun 2020) by -293.10%.

Revenues were $1.81M, better than the forecast of $1.81M by 0.00%, down by -82.27% from the previous quarter , and down by -96.32% from the same period last year.

The company reported a net income of $-39.21M.

Free cash flow for the quarter was $-53.59M , compared to $-32.45M last quarter and $-19.58M a year before.

CCXI ended the quarter with $26.53M in total debt, an increase of 2.33% compared to the previous quarter, and a decrease of -86.44% compared to the same quarter a year before.

CCXI Previous Earnings Date & Report Recap: Dec 2020 (FY)

Chemocentryx, Inc's previous annual earnings date was Mar 1, 2021 for its fiscal year ended Dec 31, 2020.

CCXI's earnings per share (EPS) was $-0.84, missing the consensus analysts forecast of $-0.74 by 13.51% , and higher than the previous year's EPS (Dec 2019) by -13.40%.

Revenues were $64.89M, worse than the forecast of $68.44M by -5.19%, and up by 80.49% from previous year's revenue.

The company reported a net income of $-55.36M.

Chemocentryx, Inc reported a free cash flow of $-96.55M for its fiscal year, compared to $-70.91M a year ago.

The company ended the fiscal year with $25.25M in total debt, an increase of 18.59% compared to the previous year.